Maat Pharma

Developer of microbiome therapy for the treatment of intestinal dysbiosis diseases

placeLyon, Auvergne Rhone Alpes, France calendar_todayFounded 2014 groups71 employees language maatpharma.com

Social engagement

Social engagement: 19.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Symbiosis, Credit Mutuel Equity, Bpifrance.

Investor typeCountShare
Venture capital431%
Private equity18%
Accelerator & incubator18%
Bank & private debt18%
Other / undisclosed646%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

28 May 2026 · IT Administration Apprentice · Lyon, France

Based on job postings tracked across public sources.

Recent activity

2 Jun 2026
Event
Lyotalk Europe 2026
Coming soon